Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

Background Cancer immunotherapy relies on using the immune system to recognize and eradicate cancer cells. Adaptive immunity, which consists of mainly antigen-specific cytotoxic T cells, plays a pivotal role in controlling cancer progression. However, innate immunity is a necessary component of the...

Повний опис

Бібліографічні деталі
Автори: Sari Pesonen, Sara Feola, Manlio Fusciello, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Jeanette Leusen, Mikaela Grönholm, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega
Формат: Стаття
Мова:English
Опубліковано: BMJ Publishing Group 2024-03-01
Серія:Journal for ImmunoTherapy of Cancer
Онлайн доступ:https://jitc.bmj.com/content/12/3/e008342.full

Інтернет

https://jitc.bmj.com/content/12/3/e008342.full

Схожі ресурси